No profile data available.
Twist Bioscience Corporation (TWST) is a healthcare company in the biological analysis equipment industry, based in South San Francisco, United States, with about 979 full-time employees.
It reported revenue of $376.57 million for fiscal year 2025, up 20.3% from fiscal year 2024, and net income of -$77.67 million. In Q3 2026 (the quarter ended June 30, 2026) revenue was $118.38 million, up 23.2% from a year before. Americas was its largest region in fiscal year 2025, with 60% of revenue. Its market capitalization was $10.59 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended September 30, 2025; market data as of October 9, 2026.
Twist Bioscience Corporation manufactures and sells synthetic DNA-based products.
Twist Bioscience reported $376.57 million in revenue for fiscal year 2025, up 20.3% from $312.97 million in fiscal year 2024. In Q3 2026 revenue was $118.38 million.
Americas: 60% of revenue by region in fiscal year 2025, followed by Europe, Middle East and Africa (33%).
$10.59 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Revvity, Inc. (RVTY), Bio-Techne Corporation (TECH), Repligen Corporation (RGEN), 10x Genomics, Inc. (TXG).